(NewsNation) — The National Institute for Health and Care Excellence is calling on healthcare services to offer structured advice and support for people ending GLP-1 weight loss drugs.

The U.K. based government-funded organization released new guidance this month highlighting the mental and physical ramifications patients can face when they stop using drugs like Mounjaro or Wegovy. NICE is recommending healthcare teams to monitor patients for a least a year after they complete treatment to maintain they progress they made with the weight loss drugs.

“The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioral interventions can help prevent weight regain and enable people to experience lasting benefits,” Dr. Rebecca Payne, Chair o

See Full Page